SMT201200064B - Composizioni per uso nel trattamento di sindromi mielodisplastiche - Google Patents

Composizioni per uso nel trattamento di sindromi mielodisplastiche

Info

Publication number
SMT201200064B
SMT201200064B SM201200064T SM201200064T SMT201200064B SM T201200064 B SMT201200064 B SM T201200064B SM 201200064 T SM201200064 T SM 201200064T SM 201200064 T SM201200064 T SM 201200064T SM T201200064 B SMT201200064 B SM T201200064B
Authority
SM
San Marino
Prior art keywords
compositions
treatment
myelodysplastic syndromes
myelodysplastic
syndromes
Prior art date
Application number
SM201200064T
Other languages
English (en)
Inventor
Gail L Brown
Lixin Meng
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of SMT201200064B publication Critical patent/SMT201200064B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201200064T 2010-06-07 2012-12-27 Composizioni per uso nel trattamento di sindromi mielodisplastiche SMT201200064B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35237410P 2010-06-07 2010-06-07
US13/108,756 US20110301199A1 (en) 2010-06-07 2011-05-16 Compositions and methods for treating myelodysplastic syndrome

Publications (1)

Publication Number Publication Date
SMT201200064B true SMT201200064B (it) 2013-03-08

Family

ID=44644899

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201200064T SMT201200064B (it) 2010-06-07 2012-12-27 Composizioni per uso nel trattamento di sindromi mielodisplastiche

Country Status (10)

Country Link
US (1) US20110301199A1 (it)
EP (1) EP2392329B1 (it)
JP (1) JP2012025734A (it)
CN (1) CN102389564A (it)
AU (1) AU2011202637A1 (it)
CA (1) CA2742032A1 (it)
DK (1) DK2392329T3 (it)
ES (1) ES2396468T3 (it)
PL (1) PL2392329T3 (it)
SM (1) SMT201200064B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759303B2 (en) * 2010-06-07 2014-06-24 Telik, Inc. Compositions and methods for treating myelodysplastic syndrome
CN109498799A (zh) * 2016-03-13 2019-03-22 曹帅 一种用于治疗骨髓增生、骨癌的药物组合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
US7189740B2 (en) * 2002-10-15 2007-03-13 Celgene Corporation Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes

Also Published As

Publication number Publication date
PL2392329T3 (pl) 2013-03-29
JP2012025734A (ja) 2012-02-09
ES2396468T3 (es) 2013-02-21
EP2392329B1 (en) 2012-10-03
DK2392329T3 (da) 2013-01-02
US20110301199A1 (en) 2011-12-08
CN102389564A (zh) 2012-03-28
CA2742032A1 (en) 2011-12-07
EP2392329A1 (en) 2011-12-07
AU2011202637A1 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
SMT201500148B (it) Composizioni per uso nel trattamento di infezioni virali
PL3023788T3 (pl) Kompozycje neoantygenów specyficznych wobec nowotworu do zastosowania w leczeniu nowotworów
PT3812360T (pt) Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
BR112012031667A2 (pt) composição
HRP20180838T1 (hr) Formuliranje deksmedetomidina u obliku predsmjese
EP2575450A4 (en) CYCLOPROPENZUSAMMENSETZUNGEN
PL2637514T3 (pl) Żelowa kompozycja
BR112012032683A2 (pt) composição
EP2893918A4 (en) ORAL COMPOSITION
BRPI1009465A2 (pt) Formulação
PL2632452T3 (pl) Związki i kompozycje stosowane w leczeniu nowotworów
IL237421A0 (en) Topical compositions and methods of use
DK2745849T3 (da) Polydeoxyribonukleotidsammensætning og anvendelser deraf
HRP20170936T1 (hr) Alkilamido spojevi i njihova uporaba
SI3138916T1 (sl) Imunogeni sestavek
EP2636704A4 (en) FILM FORMING COMPOSITION
EP2552212A4 (en) IMPROVED FORMULATION
BR112012032980A2 (pt) composição
EP2628769A4 (en) FILM FORMING COMPOSITION
EP2531023A4 (en) IMPROVED FORMULATION
EP2934694C0 (en) ANTI-PLAQUE ORAL COMPOSITIONS
SI2635269T1 (sl) Kombinacijski sestavek
EP2613344A4 (en) POLISHING COMPOSITION
BR112013016223A2 (pt) películas e composições compreendendo as mesmas
PL2729021T3 (pl) Żelowa kompozycja